Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - STERIS plcste03312018ex321.htm
EX-31.2 - EXHIBIT 31.2 - STERIS plcste03312018ex312.htm
EX-31.1 - EXHIBIT 31.1 - STERIS plcste03312018ex311.htm
EX-24.2 - EXHIBIT 24.2 - STERIS plcste03312018ex242.htm
EX-24.1 - EXHIBIT 24.1 - STERIS plcste03312018ex241.htm
EX-21.1 - EXHIBIT 21.1 - STERIS plcste03312018ex211.htm
EX-10.16 - EXHIBIT 10.16 - STERIS plcste3312016ex1016.htm
10-K - 10-K - STERIS plcste3312018.htm


Exhibit 23.1



Consent of Independent Registered Public Accounting Firm


We consent to the incorporation by reference in the following Registration Statements:

(1)
Registration Statement (Form S-8, No. 333-207721) of Steris plc and subsidiaries pertaining to the STERIS plc 2006 Long-Term Equity Incentive Plan, Assumed as Amended and Restated,
(2)
Registration Statement (Form S-8, No. 333-207722) of Steris plc and subsidiaries pertaining to the STERIS Corporation 401(k) Plan,
(3)
Registration Statement (Form S-8, No. 333-214491) of Steris plc and subsidiaries pertaining to the STERIS plc 2006 Long-Term Equity Incentive Plan;

of our reports dated May 30, 2018, with respect to the consolidated financial statements and schedule of STERIS plc and subsidiaries (STERIS) and the effectiveness of internal control over financial reporting of STERIS included in this Annual Report (Form 10-K) of STERIS for the year ended March 31, 2018.
 
/s/ Ernst & Young LLP

Cleveland, Ohio
May 30, 2018